ATE473001T1 - Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba - Google Patents

Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba

Info

Publication number
ATE473001T1
ATE473001T1 AT02769652T AT02769652T ATE473001T1 AT E473001 T1 ATE473001 T1 AT E473001T1 AT 02769652 T AT02769652 T AT 02769652T AT 02769652 T AT02769652 T AT 02769652T AT E473001 T1 ATE473001 T1 AT E473001T1
Authority
AT
Austria
Prior art keywords
pain treatment
vinyl gaba
gamma vinyl
addiction prevention
gamma
Prior art date
Application number
AT02769652T
Other languages
English (en)
Inventor
Stephen Dewey
Jonathan Brodie
Charles Ashby
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Application granted granted Critical
Publication of ATE473001T1 publication Critical patent/ATE473001T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02769652T 2001-05-14 2002-04-08 Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba ATE473001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/853,548 US20020187996A1 (en) 2001-05-14 2001-05-14 Prevention of addiction in pain management
PCT/US2002/011072 WO2002091990A2 (en) 2001-05-14 2002-04-08 Prevention of addiction in pain management

Publications (1)

Publication Number Publication Date
ATE473001T1 true ATE473001T1 (de) 2010-07-15

Family

ID=25316324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02769652T ATE473001T1 (de) 2001-05-14 2002-04-08 Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba

Country Status (21)

Country Link
US (3) US20020187996A1 (de)
EP (1) EP1392301B1 (de)
JP (1) JP2004534029A (de)
KR (1) KR20040020054A (de)
CN (1) CN100528156C (de)
AT (1) ATE473001T1 (de)
AU (1) AU2002342533B2 (de)
BR (1) BR0209613A (de)
CA (1) CA2446639C (de)
CZ (1) CZ20033380A3 (de)
DE (1) DE60236927D1 (de)
ES (1) ES2348637T3 (de)
HR (1) HRP20030892A2 (de)
HU (1) HUP0402326A3 (de)
IL (1) IL158762A0 (de)
MX (1) MXPA03010407A (de)
NO (1) NO331509B1 (de)
NZ (1) NZ529614A (de)
PL (1) PL368505A1 (de)
WO (1) WO2002091990A2 (de)
YU (1) YU89003A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1307194T2 (sl) * 2000-07-31 2011-07-29 Nycomed Danmark Aps Sestavek fentanila za nazalno dejanje
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20050043345A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN105497896A (zh) * 2015-03-31 2016-04-20 苏州大学 一种肿瘤耐药的靶点及其应用
EP4230199A4 (de) 2020-12-04 2024-07-31 Laboratorios Silanes, S.A. de C.V. Stabile beschichtete feste pharmazeutische zusammensetzung eines opioid-analgetikums und eines antiepileptikums gegen schmerzen
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6057368A (en) * 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior

Also Published As

Publication number Publication date
HUP0402326A2 (hu) 2005-02-28
US20020187996A1 (en) 2002-12-12
DE60236927D1 (de) 2010-08-19
WO2002091990A3 (en) 2003-03-27
CN1531431A (zh) 2004-09-22
US20030004176A1 (en) 2003-01-02
NZ529614A (en) 2006-08-31
US20030134868A1 (en) 2003-07-17
IL158762A0 (en) 2004-05-12
EP1392301A2 (de) 2004-03-03
JP2004534029A (ja) 2004-11-11
AU2002342533B2 (en) 2007-07-05
BR0209613A (pt) 2004-12-07
WO2002091990A2 (en) 2002-11-21
CA2446639A1 (en) 2002-11-21
US6939876B2 (en) 2005-09-06
NO331509B1 (no) 2012-01-16
CZ20033380A3 (cs) 2005-03-16
YU89003A (sh) 2006-08-17
CA2446639C (en) 2010-11-02
KR20040020054A (ko) 2004-03-06
HRP20030892A2 (en) 2005-08-31
NO20035038D0 (no) 2003-11-13
EP1392301B1 (de) 2010-07-07
EP1392301A4 (de) 2004-07-14
CN100528156C (zh) 2009-08-19
HUP0402326A3 (en) 2008-04-28
PL368505A1 (en) 2005-04-04
ES2348637T3 (es) 2010-12-10
MXPA03010407A (es) 2004-05-05

Similar Documents

Publication Publication Date Title
IL256054A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
MXPA05003501A (es) Metodos para tratamiento del dolor administrando un antagonista del factor de crecimiento del nervio y un analgesico opioide y composiciones que los contienen.
WO2004006906A3 (en) Methods for the treatment of neoplasms
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
WO2005107726A3 (en) Method for the treatment of back pain
DE60234183D1 (de) Verwendung von methylnaltrexon zur behandlung von immunsuppression
WO2002076388A3 (en) Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
ATE406159T1 (de) Behandlung von hyperlipidämie
TW200507840A (en) Method of treating multiple myeloma
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
ATE473001T1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
MY122838A (en) Treating allergic and inflammatory conditions
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
DE602006019754D1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
WO1999065475A3 (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
PT1603584E (pt) Aplidina para o tratamento de mieloma múltiplo
WO2007006732A8 (en) Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
IL166596A0 (en) Salt of morphine-6-glucoronide
MXPA04004075A (es) Compuesto y metodo para tratamiento de vejiga hiperactiva.
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
NO20054034L (no) Fremgangsmate for behandling av hypotyroidisme.
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
EP1260221A3 (de) Kombinationsbehandlung für Depression und Angstzustände
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties